SFC
NUVB icon

Swisher Financial Concepts’s Nuvation Bio NUVB Stock Holding History

Swisher Financial Concepts’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$17.6K – 95
2025
Q1 		$17.6K Buy
+10,000
New +$22.8K 0.01% 79

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Swisher Financial Concepts's NUVB Position: Q2 2025 in Review

Swisher Financial Concepts sold out of Nuvation Bio (NUVB) in Q2 2025, closing a stake of 10,000 shares — an estimated $17.6K sold.

Swisher Financial Concepts first reported a position in NUVB in Q1 2025 and held it in 1 quarter. The position peaked at $17.6K in Q1 2025. 182 funds tracked by Wall St. Rank hold NUVB as of Q2 2025.

  • Swisher Financial Concepts reported no remaining Nuvation Bio position as of Q2 2025 after selling out during the quarter.
  • Swisher Financial Concepts sold 10,000 Nuvation Bio shares in Q2 2025, an estimated $17.6K.
  • Swisher Financial Concepts first reported a position in Nuvation Bio in Q1 2025 and held it in 1 quarter.
  • Swisher Financial Concepts's Nuvation Bio position peaked at $17.6K in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2025.

Based on Swisher Financial Concepts's 13F filing for Q2 2025, filed 16 Jul 2025.